Caris MPI, Inc. is a biotechnology company based in Irving, Texas, specializing in precision medicine and molecular profiling. The organization focuses on developing advanced diagnostic solutions that enhance personalized treatment strategies for patients, particularly in oncology. By leveraging cutting-edge technologies, Caris MPI aims to provide comprehensive insights into tumor biology, enabling healthcare providers to make informed decisions tailored to individual patient needs. Their commitment to innovation positions them as a key player in the evolving landscape of personalized healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

22 Patents

#17 in Irving, TX

#889 in Texas

#15,021 in US

#28,749 in the World

Irving, TX, United States of America

Caris Mpi, Inc.

Forward Citations = 193

16 inventors:

Robert J Penny (17 out of 17 patents)

Daniel D Von Hoff (17 out of 20 patents)

Matthew J McGinniss (11 out of 26 patents)

4. David M Loesch (11 out of 11 patents)

5. Arlet Alarcon (11 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Caris Mpi, Inc.. Retrieved from https://idiyas.com/company/caris-mpi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]